Developing endpoints for the cognitive burden in myotonic dystrophy type 1: A workshop report
Myotonic Dystrophy Type 1 (DM1) is an autosomal dominant, repeat expansion, progressive multisystem disorder. While central nervous system (CNS) involvement has been well established, a consensus on a dedicated protocol to assess cognitive function and collect CNS biomarkers is still lacking in this disease. In the era of disease-modifying therapies that cross the blood-brain barrier (BBB), availability of mechanistically relevant neuropsychological probes and reliable biomarkers of DM1 pathology is no longer deferrable. Consequently, to better define and harmonize a CNS assessment pathway, the Myotonic Dystrophy Clinical Research Network (DMCRN) convened a workshop entitled ‘‘Myotonic Dystrophy CNS Workshop’’ in September 2024. Presenters described the protean manifestations of CNS involvement in DM1, shared data about neuropsychological assessments available with cross-fertilization from other neurological and neurodegenerative diseases and discussed existing data and future perspectives on CNS radiological biomarkers.
Authors
- Eric T. Wang (ORCID: https://orcid.org/0000-0003-2655-5525)
- Nicholas Elwood Johnson (ORCID: https://orcid.org/0000-0002-3917-4257)
- Julie B. Eisengart (ORCID: https://orcid.org/0000-0001-5340-017X)
- Valeria Sansone (ORCID: https://orcid.org/0000-0002-1354-3800)
- Carola Rita Ferrari Aggradi (ORCID: https://orcid.org/0009-0002-8621-2161)
- Belinda S. Pinto
- Belen Esparis
- Eric C. Porges (ORCID: https://orcid.org/0000-0003-3885-5859)
- James Matthew Bjork (ORCID: https://orcid.org/0000-0003-0593-3291)
- Dorene M. Rentz (ORCID: https://orcid.org/0000-0002-6318-9213)
- Sub H. Subramony (ORCID: https://orcid.org/0000-0002-8052-9240)
Institutions
- University of Minnesota (US)
- Harvard University (US)
- Virginia Commonwealth University (US)
- University of Milan (IT)
- University of California, Irvine (US)
- University of Florida (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Journal of Neuromuscular Diseases
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1177/22143602261503402
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00